
- Rigel Pharmaceuticals (RIGL) is showing exceptional momentum, setting new 52-week highs on Aug. 22.
- Shares are up nearly 243% over the past year.
- The stock is trading above key moving averages and is supported by several “Strong Buy” analyst ratings.
- Fundamentals show impressive projected earnings growth this year, but both revenue and earnings are forecast to decline next year, raising caution.